Omron Corp. (OTCMKTS:OMRNY - Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $37.05, but opened at $40.14. Omron shares last traded at $40.4450, with a volume of 5,714 shares.
Analysts Set New Price Targets
Separately, Zacks Research raised Omron from a "strong sell" rating to a "hold" rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Omron has an average rating of "Hold".
Read Our Latest Stock Report on Omron
Omron Price Performance
The business has a fifty day moving average of $30.82 and a 200-day moving average of $28.21. The firm has a market cap of $7.91 billion, a PE ratio of 50.95, a PEG ratio of 0.43 and a beta of 1.16. The company has a current ratio of 2.11, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13.
Omron (OTCMKTS:OMRNY - Get Free Report) last announced its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.19). The business had revenue of $1.41 billion during the quarter, compared to the consensus estimate of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%. As a group, research analysts predict that Omron Corp. will post 1.22 earnings per share for the current year.
Hedge Funds Weigh In On Omron
An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC raised its position in shares of Omron Corp. (OTCMKTS:OMRNY - Free Report) by 50.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,129 shares of the company's stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC's holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is owned by institutional investors.
Omron Company Profile
(
Get Free Report)
Omron Corporation OTCMKTS: OMRNY is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.
While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.